About this Webinar
Updates to the Global Data 10-year forecast for healthcare spending and pharmaceutical sales
• Major drivers for the changes to the outlook
o Drug shortages as a policy driver
o Early launch incentives in Japan
o Insulin OOP caps (US), reimportation (Florida) and price negotiation under Inflation Reduction Act in US
o EU reform: IP protection extension in exchange for simultaneous launch
o Compulsory licensing in Russia and industry responses
o Subscription plans for Antimicrobials
• Outlook
• Q&A – 10 min
Speakers
Milena Izmirlieva
Milena Izmirlieva heads GlobalData’s Health Economics and Market Access research and analysis team, which comprises senior analysts, analysts, and health economists covering developed and emerging markets worldwide. Since joining one of GlobalData’s predecessor companies in 2003 as a pharma research analyst for Western European and Central and Eastern European markets, she has developed extensive knowledge of the healthcare systems and pharmaceutical markets of numerous countries in Europe, North America, and various emerging markets.
Prior to that, Milena worked in healthcare marketing communications for the EURO RSCG group in New York, US, and Sofia, Bulgaria, where she specialized in pharmaceutical and medical device companies. Her main areas of research interest are pricing and reimbursement and market access for originator drugs; the market dynamics for biosimilars and generics; health system efficiency indicators and health system capacity; and forecasting healthcare spending and pharmaceutical sales.
She holds an MSc degree in Health Economics, Policy, and Management from the London School of Economics and Political Science (LSE), an MSc degree in Communication with a focus on Science Writing from Iowa State University, and a joint BA degree in Journalism, Mass Communication, and International Relations from the American University in Bulgaria. Milena is a regular speaker at pharmaceutical conferences and is often interviewed about pharmaceutical-related issues in the media.
She frequently presents peer-reviewed research at ISPOR and has a strong interest in pharmaceutical pricing and reimbursement developments and cost-containment strategies (including international reference pricing).
Eoin Martin Ryan
Eoin Ryan is Senior Research Analyst for Europe and the Manager of the Europe Health Economics and Market Access Research and Analysis team.
Eoin joined one of the GlobalData predecessor companies in 2008 as a research analyst for Western Europe and has since developed extensive expertise in healthcare and pharma market analysis.
Prior to that, he worked for the IHS Markit Economics and Country Risk team. His areas of expertise include pharmaceutical regulation and healthcare policy.
Eoin holds a Master of Arts degree in International Relations from University College Dublin and a Master of Science degree in Health Policy and Economics from the London School of Economics and Political Science (LSE).
Chia Hsuan Lin
Chia Lin provides coverage and analysis of healthcare and market access developments in the Asia-Pacific region.
Chia joined GlobalData in 2022 as a research analyst and is responsible for providing analysis of healthcare policy, pricing and reimbursement, and market access developments in Asia-Pacific markets.
She holds a master’s degree in international relations from King’s College London and a bachelor’s degree in humanities and social sciences from the National Tsing Hua University. Prior to joining GlobalData, Chia worked for McAndrew Leadership, an NPO consulting company. She is fluent in English and Mandarin.Chia Lin provides coverage and analysis of healthcare and market access developments in the Asia-Pacific region.
Chia joined GlobalData in 2022 as a research analyst and is responsible for providing analysis of healthcare policy, pricing and reimbursement, and market access developments in Asia-Pacific markets.
She holds a master’s degree in international relations from King’s College London and a bachelor’s degree in humanities and social sciences from the National Tsing Hua University. Prior to joining GlobalData, Chia worked for McAndrew Leadership, an NPO consulting company. She is fluent in English and Mandarin.
Choukri Genane
TBC
Cyrus Fan
Cyrus Fan is a Research Analyst in the GlobalData Life Sciences team focusing on the US and Canadian markets. Cyrus is responsible for daily analysis on these markets, providing updates on pricing and reimbursement, market access, regulatory and policy developments which affect the pharmaceutical industry. In addition, he is responsible for providing deeper analysis in special reports on specific topics and for producing GlobalData’s Market Access Month Ahead report. Before joining GlobalData, Cyrus completed his PhD in Diabetes, Endocrinology and Metabolism in January 2022 and holds an MSci in Pharmacology, both degrees completed at King’s College London. He is fluent in English and speaks conversational Chinese Cantonese.
Janet Beal
Janet is a Senior Research Analyst on GlobalData's health economics and market access team, which she joined (in a predecessor company) eight years ago. She covers European and Eurasian markets, with her main focuses on the UK, Switzerland, Romania, and Russia and other CIS countries. She has extensive experience in coverage of the pharma sector, particularly biotech R&D, gained over several years at Informa Citeline, Thomson Derwent, and the British Library. She has an MSc in Biochemistry and Applied Molecular Biology from UMIST (Manchester), and a BSc in Microbiology from Aberdeen University.
Past Webinars
View more past webinarsUpcoming Webinars
View more upcoming webinarsSearch companies, themes, reports, as well as actionable data & insights spanning 22 global industries
Access more premium companies when you subscribe to Explorer